These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Treatment of myocardial infarct on the job site in a large industrial medicine ambulance]. Schuckmann F Zentralbl Arbeitsmed; 1970 Oct; 20(10):301-3. PubMed ID: 5475307 [No Abstract] [Full Text] [Related]
10. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592 [TBL] [Abstract][Full Text] [Related]
11. Intravenous versus intracoronary streptokinase therapy for acute myocardial infarction in community hospitals. Taylor GJ; Mikell FL; Moses HW; Dove JT; Batchelder JE; Thull A; Hansen S; Wellons HA; Schneider JA Am J Cardiol; 1984 Aug; 54(3):256-60. PubMed ID: 6465000 [TBL] [Abstract][Full Text] [Related]
12. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction. Seabra-Gomes R; Aniceto Silva J; Aleixo A; Real T; Freire I; Torres I; Freitas R; Crespo F Drugs; 1987; 33 Suppl 3():169-74. PubMed ID: 3315586 [TBL] [Abstract][Full Text] [Related]
14. [Prehospital thrombolysis. Evaluation of preliminary experiences at Val-de-Marne]. Dubois-Randé JL; Herve C; Duval-Moulin AM; Gaillard M; Boesch C; Louvard Y; Wolf M; Jan F; Castaigne A Arch Mal Coeur Vaiss; 1989 Dec; 82(12):1963-6. PubMed ID: 2515822 [TBL] [Abstract][Full Text] [Related]
15. Residual coronary stenoses and calculated transstenotic gradients after intravenous streptokinase versus tissue plasminogen activator. Kimball BP; Bui S; Ling A; Dafopoulos N Am Heart J; 1992 Jan; 123(1):7-14. PubMed ID: 1729852 [TBL] [Abstract][Full Text] [Related]
16. Intravenous versus intracoronary streptokinase for acute transmural myocardial infarction. Blunda M; Meister SG; Shechter JA; Pickering NJ; Wolf NM Cathet Cardiovasc Diagn; 1984; 10(4):319-27. PubMed ID: 6488304 [TBL] [Abstract][Full Text] [Related]
17. Bedside intracoronary thrombolysis in the coronary care unit. Babić U; Pejcić P; Djuricić Z; Grujicić S; Janković S; Vucinić M Cor Vasa; 1987; 29(1):1-8. PubMed ID: 3581835 [TBL] [Abstract][Full Text] [Related]
18. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. GUSTO Angiographic Investigators N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430 [TBL] [Abstract][Full Text] [Related]
19. High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis. MacLennan BA; McMaster A; Webb SW; Khan MM; Adgey AA Br Heart J; 1986 Mar; 55(3):231-9. PubMed ID: 3954907 [TBL] [Abstract][Full Text] [Related]
20. Prehospital use of APSAC: results of a placebo-controlled study. Castaigne AD; Hervé C; Duval-Moulin AM; Gaillard M; Dubois-Rande JL; Boesch C; Wolf M; Lellouche D; Jan F; Vernant P Am J Cardiol; 1989 Jul; 64(2):30A-33A; discussion 41A-42A. PubMed ID: 2662741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]